# A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

> **NCT02175056** · PHASE1 · COMPLETED · sponsor: **Handok Inc.** · enrollment: 58 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** HL2351
- **BIOLOGICAL:** Kineret(Anakinra)

## Key facts

- **NCT ID:** NCT02175056
- **Lead sponsor:** Handok Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02175056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02175056, "A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02175056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*